{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:04:41Z","timestamp":1789556681709,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Study on the Relationship Between Transthyroxine Cardiac Amyloidosis Incidence and Atrial Fibrillation in Plateau Regions","award":["2025YFKT-QN-16"],"award-info":[{"award-number":["2025YFKT-QN-16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-026-03727-4","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:04:13Z","timestamp":1778893453000},"page":"1709-1721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the diagnostic value of dual-time-point, multi-parameter 99mTc-PYP imaging in diagnosing Transthyretin Cardiac Amyloidosis"],"prefix":"10.1007","volume":"42","author":[{"given":"Jinyong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"3","key":"3727_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.12125\/j.chj.202308086","volume":"37","author":"C Ai-yuan","year":"2025","unstructured":"Ai-yuan C, Jian-hua H, Xing Q, Tao S, Yu-kun C, Rui W, Qiong W (2025) A case report of transthyretin cardiac amyloidosis diagnosed by myocardial biopsy. Chin Heart J 37(3):368\u2013371. https:\/\/doi.org\/10.12125\/j.chj.202308086[in Chinese]","journal-title":"Chin Heart J"},{"issue":"5","key":"3727_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7652\/jdyxb202405014","volume":"45","author":"F Chong","year":"2024","unstructured":"Chong F, Leilei P, Chun Y, Tao Z, Wenjin Z, Shun W (2024) Significance of echocardiography in distinguishing between two main subtypes of myocardial amyloidosis. J Xi\u2019an Jiaotong Univ (Medical Edition) 45(5):789\u2013793. https:\/\/doi.org\/10.7652\/jdyxb202405014[in Chinese]","journal-title":"J Xi\u2019an Jiaotong Univ (Medical Edition)"},{"issue":"4","key":"3727_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.13705\/j.issn.1671-6825.2024.03.027","volume":"59","author":"P Yang","year":"2024","unstructured":"Yang P, Liu Z, Zheng Y, Zhang W, Wang Y, Xiao L, Liu G (2024) Genetic analysis of a pedigree of transthyretin amyloid cardiomyopathy. J Zhengzhou Univ (Medical Science) 59(4):582\u2013586. https:\/\/doi.org\/10.13705\/j.issn.1671-6825.2024.03.027[in Chinese]","journal-title":"J Zhengzhou Univ (Medical Science)"},{"issue":"9","key":"3727_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/ejhf.2589","volume":"24","author":"AS Antonopoulos","year":"2022","unstructured":"Antonopoulos AS, Panagiotopoulos I, Kouroutzoglou A et al (2022) Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis. Eur J Heart Fail 24(9):1677\u20131696. https:\/\/doi.org\/10.1002\/ejhf.2589","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"3727_CR5","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","volume":"68","author":"M Grogan","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA et al (2016) Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System. J Am Coll Cardiol 68(10):1014\u20131020. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"key":"3727_CR6","doi-asserted-by":"publisher","first-page":"1075806","DOI":"10.3389\/fcvm.2022.1075806","volume":"9","author":"Y Razvi","year":"2023","unstructured":"Razvi Y, Porcari A, Di Nora C, Patel RK, Ioannou A, Rauf MU, Masi A, Law S, Chacko L, Rezk T, Ravichandran S, Gilbertson J, Rowczenio D, Blakeney IJ, Kaza N, Hutt DF, Lachmann H, Wechalekar A, Moody W, Lim S, Gillmore JD (2023) Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience. Front Cardiovasc Med 9:1075806. https:\/\/doi.org\/10.3389\/fcvm.2022.1075806","journal-title":"Front Cardiovasc Med"},{"key":"3727_CR7","doi-asserted-by":"publisher","first-page":"1154594","DOI":"10.3389\/fcvm.2023.1154594","volume":"10","author":"D Tomasoni","year":"2023","unstructured":"Tomasoni D, Bonfioli GB, Aimo A, Adamo M, Canepa M, Inciardi RM, Lombardi CM, Nardi M, Pagnesi M, Riccardi M, Vergaro G, Vizzardi E, Emdin M, Metra M (2023) Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials. Front Cardiovasc Med 10:1154594. https:\/\/doi.org\/10.3389\/fcvm.2023.1154594","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"3727_CR8","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Linhart A (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 42(16):1554\u20131568. https:\/\/doi.org\/10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"3727_CR9","doi-asserted-by":"publisher","unstructured":"Li H, Sijin L (2022) Procedure guideline of 99 Tcm \u2043pyrophosphate scintigraphy in the diagnosis of transthyretin\u2043related cardiac amyloidosis (Vol. 42, Issue 3, pp. 165\u2013171). https:\/\/doi.org\/10.3760\/cma.j.cn321828-20210909-00320. [in Chinese]","DOI":"10.3760\/cma.j.cn321828-20210909-00320"},{"issue":"3S","key":"3727_CR10","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.hfc.2024.09.007","volume":"20","author":"V Musetti","year":"2024","unstructured":"Musetti V, Greco F, Aimo A, Castiglione V, Vergaro G, Panichella G, Limongelli G, Merlo M, Emdin M, Pucci A (2024) Cardiac Amyloidosis: Role of the Endomyocardial Biopsy. Heart Fail Clin 20(3S):e23\u2013e31. https:\/\/doi.org\/10.1016\/j.hfc.2024.09.007","journal-title":"Heart Fail Clin"},{"issue":"7","key":"3727_CR11","doi-asserted-by":"publisher","first-page":"e000030","DOI":"10.1161\/HCI.0000000000000030","volume":"14","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S et al (2021) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Circ Cardiovasc Imaging 14(7):e000030. https:\/\/doi.org\/10.1161\/HCI.0000000000000030","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"3727_CR12","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s12350-020-02455-z","volume":"28","author":"S Dorbala","year":"2021","unstructured":"Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AW, Hanna MA (2021) Addendum to ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging. Journal of Nuclear Cardiology 28(4):1769-74. https:\/\/doi.org\/10.1007\/s12350-020-02455-z","journal-title":"J nuclear cardiology: official publication Am Soc Nuclear Cardiol"},{"issue":"2","key":"3727_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2967\/jnmt.123.265416","volume":"51","author":"EJ Schockling","year":"2023","unstructured":"Schockling EJ, Farrell MB, Embry-Dierson M, Warren J, Jerome S (2023) Cardiac Amyloidosis Imaging, Part 2: Quantification and Technical Considerations. J Nucl Med Technol 51(2):90\u201398. https:\/\/doi.org\/10.2967\/jnmt.123.265416","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"3727_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jama.2020.5493","volume":"324","author":"MA Gertz","year":"2020","unstructured":"Gertz MA, Dispenzieri A (2020) Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review. JAMA 324(1):79\u201389. https:\/\/doi.org\/10.1001\/jama.2020.5493","journal-title":"JAMA"},{"issue":"20","key":"3727_CR15","doi-asserted-by":"publisher","first-page":"e33817","DOI":"10.1097\/MD.0000000000033817","volume":"102","author":"KJ Nichols","year":"2023","unstructured":"Nichols KJ, Yoon SY, Van Tosh A, Palestro CJ (2023) 1-hour versus 3-hour 99mTc-PYP imaging to evaluate suspected cardiac transthyretin amyloidosis. Medicine 102(20):e33817. https:\/\/doi.org\/10.1097\/MD.0000000000033817","journal-title":"Medicine"},{"issue":"1","key":"3727_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40658-020-00342-7","volume":"8","author":"C Ren","year":"2021","unstructured":"Ren C, Ren J, Tian Z, Du Y, Hao Z, Zhang Z, Fang W, Li F, Zhang S, Hsu B, Huo L (2021) Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT. EJNMMI Phys 8(1):3. https:\/\/doi.org\/10.1186\/s40658-020-00342-7","journal-title":"EJNMMI Phys"},{"issue":"18","key":"3727_CR17","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1093\/cvr\/cvac119","volume":"118","author":"A Porcari","year":"2023","unstructured":"Porcari A, Fontana M, Gillmore JD (2023) Transthyretin cardiac amyloidosis. Cardiovascular Res 118(18):3517\u20133535. https:\/\/doi.org\/10.1093\/cvr\/cvac119","journal-title":"Cardiovascular Res"},{"issue":"2","key":"3727_CR18","first-page":"109","volume":"16","author":"GT Krishnamurthy","year":"1975","unstructured":"Krishnamurthy GT, Huebotter RJ, Walsh CF, Taylor JR, Kehr MD, Tubis M, Blahd WH (1975) Kinetics of 99mTc-labeled pyrophosphate and polyphosphate in man. J nuclear medicine: official publication Soc Nuclear Med 16(2):109\u2013115","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"issue":"1","key":"3727_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/diagnostics12010094","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Pan R, Peng D, Dong Q, Zhu X (2022) Pitfalls of the Semi-Quantitative Analyzing 99mTc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution. Diagnostics (Basel Switzerland) 12(1):94. https:\/\/doi.org\/10.3390\/diagnostics12010094","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"11","key":"3727_CR20","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","volume":"22","author":"CC Quarta","year":"2021","unstructured":"Quarta CC, Zheng J, Hutt D, Grigore SF, Manwani R, Sachchithanantham S, Mahmood SA, Whelan CJ, Fontana M, Martinez-Naharro A, Chacko L, Lachmann HJ, Gillmore JD, Rapezzi C, Hawkins PN, Wechalekar AD (2021) 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. European heart journal. Cardiovasc Imaging 22(11):1304\u20131311. https:\/\/doi.org\/10.1093\/ehjci\/jeab095","journal-title":"Cardiovasc Imaging"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03727-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-026-03727-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-026-03727-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:29:35Z","timestamp":1789554575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-026-03727-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["3727"],"URL":"https:\/\/doi.org\/10.1007\/s10554-026-03727-4","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}